Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of Weighted-Average Common Shares Outstanding

The following securities are included in the weighted-average common shares outstanding used to calculate basic and diluted net loss per common share:

	Years Ended December 31,
	2024		2023		2022
Common stock		37,689,804		15,040,036		7,409,165
March 2022 pre-funded warrants		-		290,665		987,923
May 2023 Tranche A pre-funded exchange warrants		1,685,181		778,904		-
May 2023 Tranche B pre-funded exchange warrants		373,892		92,801		-
October 2023 pre-funded warrants		427,049		289,726		-
Total		40,175,926		16,492,132		8,397,088

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares):

	Years Ended December 31,
	2024		2023		2022
Warrants issued to 2010/2012 convertible note holders to purchase common stock		-		6,804		6,804
Warrants issued to underwriter to purchase common stock		-		1,100		1,100
2018 PIPE warrants		-		-		34,241
March 2022 common warrants		1,255,346		1,929,066		4,000,000
May 2023 Tranche B warrants		2,065,305		6,750,000		-
Options to purchase common stock		3,971,798		2,369,665		686,574
Outstanding restricted stock units		939,865		15,534		19,068
Total		8,232,314		11,072,169		4,747,787